Thus, a cellular model of AD with okadaic acid (OA) treatment was used to induce tau hyperphosphorylation in primary cultures of neurons from WT or Ncf1−/− newborn mice and to verify whether p47phox deletion could alleviate tau hyperphosphorylation. This evidence concerns the gene MAPT and Alzheimer disease.